UBS Group »

Cue Biopharma shares owned by UBS Group

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $262k 99k 2.64
2023-09-30 $182k 79k 2.30
2023-06-30 $293k 80k 3.65
2023-03-31 $207k 58k 3.57
2022-12-31 $69k 24k 2.85
2022-09-30 $54k 24k 2.24
2022-06-30 $73k 28k 2.57
2022-03-31 $133k 26k 5.19
2021-12-31 $1.2M 109k 11.30
2021-09-30 $855k 59k 14.59
2021-06-30 $314k 27k 11.62
2021-03-31 $640k 52k 12.20
2020-12-31 $288k 23k 12.77
2020-09-30 $325k 22k 15.05
2020-06-30 $529k 22k 24.50
2020-03-31 $439k 31k 14.18
2019-12-31 $933k 59k 15.86
2019-09-30 $409k 49k 8.42
2019-06-30 $326k 36k 8.99
2019-03-31 $274k 30k 9.01
2018-12-31 $175k 37k 4.69
2018-09-30 $235k 26k 9.00
2018-06-30 $279k 23k 12.06
2018-03-31 $53k 3.7k 14.23